Base title: prevent preclinical drug development program: preclinical efficacy and intermediate biomarkers task order title: preventing FAP-CRC using rlon protease in pirc RAT model
Ended Awarded Last action
- Contract number
- 75N91022F00001
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $139,980
Award facts
- Contract value 100% obligated
- $139,980.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,347 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $143,327 |
About this award
This federal contract award is for a task order under the National Institutes of Health's (NIH) "PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarkers" program. The $139,980.00 task order was awarded to the University of Oklahoma (OU) to support research on preventing familial adenomatous polyposis-associated colorectal cancer (FAP-CRC) using an RLON protease in the PIRC rat model. This is a firm fixed price delivery order contract with a completion date of December 27, 2023. The contract was awarded on June 28, 2022 and does not have a set-aside designation.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on June 28, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $139,980 on 75N91022F00001.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a delivery order under 75N91019D00020, an indefinite delivery contract, on PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award